Biotech · Private company
Fortis Therapeutics, Inc.
Track this companyFree. Adds Fortis Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials53 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- FOR46Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- FOR46Phase 1 · Prostate Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Imaging Study of [89Zr]DFO-YS5 for Cancer DetectionPHASE1 · RECRUITING · started Jun 15, 2026ClinicalTrials.gov NCT07664397 · fetched Nov 12, 2026
- PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 18, 2022ClinicalTrials.gov NCT05245006 · fetched Nov 12, 2026
- FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 19, 2022ClinicalTrials.gov NCT05011188 · fetched Nov 12, 2026
- A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)PHASE1 · COMPLETED · started Apr 3, 2019ClinicalTrials.gov NCT03650491 · fetched Nov 12, 2026
- A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)PHASE1 · COMPLETED · started Feb 4, 2019ClinicalTrials.gov NCT03575819 · fetched Nov 12, 2026